Skip to main content
Steven Idell, MD, Pulmonology, Tyler, TX

Steven Idell MD

Pulmonology•Tyler, TX

Critical Care Medicine, Pleural Disease

Physician

Join to view full profile

  • 11937 Us Highway 271Tyler, TX 75708

  • Phone+1 903-877-7777

  • Fax+1 903-877-5838

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
Join DoximityAlready have an account?

Summary

  • Dr. Steven Idell, MD is a pulmonologist in Tyler, Texas. He is currently licensed to practice medicine in Texas.

Education & Training

  • Temple University Hospital
    Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1983
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1977 - 1980
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1977

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1985 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification MEDITECH Client/Server Public Health Interface: Transmission to Immunization Registries, Medical Information Technology, Inc. (MEDITECH), 2013, 2016-2017
  • CMS Meaningful Use Stage 2 Certification ENCOR, Medisolv Inc, 2013, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Medical and Practice Management (MPM) Client/Server Patient and Consumer Health Portal, LSS Data Systems, 2013, 2016-2017

Publications & Presentations

PubMed

Press Mentions

  • Monopar and NorthStar Collaborating with Texas Lung Injury Institute for Testing of Novel Potential Therapeutic for Severe COVID-19
    Monopar and NorthStar Collaborating with Texas Lung Injury Institute for Testing of Novel Potential Therapeutic for Severe COVID-19September 9th, 2020
  • East Texas Researchers Studying More Effective Treatments for Cancer, Other Incurable Diseases
    East Texas Researchers Studying More Effective Treatments for Cancer, Other Incurable DiseasesJanuary 30th, 2020
  • UTHSC: $1.4 Million Grant Renewal to Inspire Tuberculosis Research at Tyler Research Center
    UTHSC: $1.4 Million Grant Renewal to Inspire Tuberculosis Research at Tyler Research CenterNovember 5th, 2019

Grant Support

  • Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyemaUNIVERSITY OF TEXAS HLTH CTR AT TYLER2017–2025

Dr. Steven Idell, Dr. Steven Idell, MD, Dr. S Idell